European Multicenter Study of ET-COVID-19Fédérico Cagnazzo, Raffaele Augelli, Nader Sourour et al.|Stroke|2020Cited by 35
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor StrokeEleonora De Matteis, Giampietro Ruzza, Federico De Santis et al.|Stroke|2023Cited by 34
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study CohortRaffaele Ornello, Simone Beretta, Matteo Foschi et al.|Journal of the American Heart Association|2024Cited by 12
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study CohortMatteo Foschi, Daniele Orsucci, Lucio D’Anna et al.|Stroke|2024Cited by 5
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attackFederico De Santis, Roberto Tarletti, Eleonora De Matteis et al.|Therapeutic Advances in Neurological Disorders|2025Cited by 1